menu search

Coherus biosciences launches biosimilar version of abbvie's blockbuster humira

Coherus BioSciences said on Monday it has launched a copycat version of AbbVie's Humira in the United States at a discount of over 85% to the blockbus...

July 3, 2023, 9:12 am

Organon, samsung bioepis launch copycat for arthritis drug humira at 85% discount

Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie's blockbuster ...

July 1, 2023, 8:04 am

Organon, samsung bioepis launch copycat for athritis drug humira at 85% discount

Drugmaker partners Organon and Samsung Bioepis said on Saturday that they had launched a far cheaper copycat version of AbbVie's blockbuster ...

July 1, 2023, 6:38 am

Sandoz launches rival version of abbvie's arthritis drug humira

Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc's big selling arthr...

July 1, 2023, 12:20 am

For abbvie's blockbuster humira, cheaper competitors pose surprisingly little threat, analysts say

AbbVie's ABBV, +1.53% rheumatoid arthritis drug Humira, one of the top-selling biopharmaceutical produc...

June 30, 2023, 1:28 pm

Nfl alumni health and paradigm anticipate touchdown for unmet osteoarthritis pain

NFL Alumni support ex-NFL players with medical symposium during NFL Draft Mount Laurel, NJ, June 27, 2023 (GLOBE NEWSWIRE) — In tandem with the NFL ...

June 27, 2023, 5:03 pm

Psoriatic arthritis therapeutics market to grow at a cagr of 8.0% from 2022 to 2031, reaching usd 24.2 billion: as per tmr study

Technological advancements in drug delivery system, is another factor that is anticipated to stimulate the psoriatic ...

June 23, 2023, 8:30 pm

Unitedhealth unit to add boehringer's humira biosimilar to reimbursement list

Boehringer Ingelheim's biosimilar of AbbVie Inc's blockbuster arthritis drug Humira will be included in...

June 23, 2023, 12:23 pm

Abbvie, coherus agree to resolve dispute over humira biosimilar

Coherus BioSciences Inc said on Thursday it had agreed to resolve a dispute over its plans to launch a lower-priced version of AbbVie Inc's Humira, it...

June 15, 2023, 7:10 am

Why aclaris therapeutics topped the market on tuesday

The biotech has completed enrollment in the next phase of an important development program. It is aiming to get a rheumatoid ...

June 13, 2023, 6:30 pm

Dr. reddy's (rdy) meets goals in actemra biosimilar study

Dr. Reddy's (RDY) announces meeting primary and secondary endpoints in the phase I study of its proposed tocilizumab biosimilar for the treatment of r...

June 6, 2023, 7:59 am

Coherus biosciences to launch humira biosimilar at $995 per carton

Coherus BioSciences Inc said on Thursday it plans to launch a biosimilar of AbbVie Inc's blockbuster arthritis...

June 1, 2023, 9:24 am

Hip replacement implants market is likely to reach usd 7.0 bn by 2031 growing with cagr of 4.0%: tmr study

Significant rise in adoption of total hip arthroplasty (THA) procedures for end-stage degenerative hip osteoar...

May 11, 2023, 2:30 pm

Galapagos stands strong on jyseleca positive clinical data

Galapagos' focuses on immunology and oncology, with its flagship Jyseleca being used to treat rheumatoid arthr...

May 6, 2023, 1:59 am

Cult food science announces mou with jellatech to create collagen-enhanced pet foods

CULT Food Science Corp (CSE:CULT, OTCQB:CULTF) has announced a partnership with JellaTech, a company producing collagen through cellular agriculture,...

April 11, 2023, 8:03 am

Axial spondyloarthritis management market is expected to reach us$ 7.3 billion, & expected to grow with a 5.1% cagr during 2023 to 2033 | future market insights, inc.

Hospitals Expected to Hold 40% Of Market Share for Axial Spondyloarthritis Management Market. North Ame...

March 31, 2023, 11:30 am

Nurix's stock rallies on gilead's option

Shares of Nurix Therapeutics Inc. NRIX, -0.99% gained about 6% in premarket trading on Monday after Gilead Sciences Inc. GILD, -3.18% said it exercise...

March 20, 2023, 9:00 am

[trending] global rheumatoid arthritis drugs market size & share to hit $ 70.1 billion by 2030 at a 1.75% cagr: growing cases of rheumatoid arthritis to propel market demand- facts & factors

The global rheumatoid arthritis drugs market size was valued at USD 60.1 billion in 2021 and is expecte...

February 10, 2023, 9:10 am

The global orthobiologics market valued at $6 billion (2023), is set to witness a growth rate of 3% in the next 10 years | future market insights, inc.

Orthobiologics Market – Patients Suffering from arthritis and Other Spine Disorders. Rising incidence...

February 9, 2023, 4:30 pm


Search within

Pages Search Results: